Advertisement

Archives of Virology

, Volume 164, Issue 10, pp 2559–2563 | Cite as

MTTP polymorphisms and hepatic steatosis in individuals chronically infected with hepatitis C virus

  • Thamiris Vaz Gago Prata
  • Dayane de Souza Rodrigues da Silva
  • Caroline Manchiero
  • Bianca Peixoto Dantas
  • Celso Carmo Mazza
  • Arielle Karen da Silva Nunes
  • Edson Abdala
  • Gerusa Maria Figueiredo
  • Fátima Mitiko Tengan
  • Mariana Cavalheiro MagriEmail author
Brief Report

Abstract

Polymorphisms in the microsomal triglyceride transfer protein (MTTP) gene were genotyped in individuals who were chronically infected with hepatitis C virus (HCV). In the 236 patients, the frequencies of risk alleles of the -164T/C (rs1800804), -400A/T (rs1800803) and H297Q (rs2306985) polymorphisms were 0.30, 0.41 and 0.50, respectively. A significant association between the risk alleles of the -164T/C and -400A/T polymorphisms combined with HCV genotype 3 infection and the occurrence of steatosis was detected (p = 0.004 and p = 0.032), suggesting that a combination of host and viral factors can potentially be used to predict hepatic steatosis.

Notes

Funding

This study was funded by the Sao Paulo Research Foundation (FAPESP) via grant #2016/19690-5.

Compliance with ethical standards

Conflict of interest

All authors declare no conflict of interest.

Ethical approval

This research received the approval of the Ethics Committee for Research Projects Analysis (CAPPesq) of the Clinical Hospital, School of Medicine, University of Sao Paulo, Brazil, #1.645.384/2016, and was performed according to the Declaration of Helsinki. All data were analyzed anonymously.

Informed consent

The participants involved in this research signed an informed consent statement.

Supplementary material

705_2019_4352_MOESM1_ESM.docx (103 kb)
Supplementary material 1 (DOCX 103 kb)

References

  1. 1.
    World Health Organization (2018) Hepatitis C. http://www.who.int/mediacentre/factsheets/fs164/en/. Accessed 20 March 2019
  2. 2.
    Khan M, Jahan S, Khaliq S, Ijaz B, Ahmad W, Samreen B, Hassan S (2010) Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis. Arch Virol 155(11):1735–1753.  https://doi.org/10.1007/s00705-010-0797-7 CrossRefGoogle Scholar
  3. 3.
    Li XL, Sui JQ, Lu LL, Zhang NN, Xu X, Dong QY et al (2016) Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise review. Lipids Health Dis 15:53.  https://doi.org/10.1186/s12944-016-0221-8 CrossRefGoogle Scholar
  4. 4.
    Manchiero C, Nunes AKS, Magri MC, Dantas BP, Mazza CC, Barone AA et al (2017) The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C. BMC Infect Dis 17(1):780.  https://doi.org/10.1186/s12879-017-2887-6 CrossRefGoogle Scholar
  5. 5.
    Milano M, Aghemo A, Mancina RM, Fischer J, Dongiovann P, Nicola S et al (2015) Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients. Hepatology 62(1):111–117.  https://doi.org/10.1002/hep.27811 CrossRefGoogle Scholar
  6. 6.
    Okumura K, Imamura A, Murakami R, Takahashi R, Cheng XW, Numaguchi Y et al (2009) Microsomal triglyceride transfer protein gene polymorphism strongly influences circulating malondialdehyde-modified low-density lipoprotein. Metabolism 58(9):1306–1311.  https://doi.org/10.1016/j.metabol.2009.04.013 CrossRefGoogle Scholar
  7. 7.
    Zampino R, Ingrosso D, Durante-Mangoni E, Capasso R, Tripodi MF, Restivo L et al (2008) Microsomal triglyceride transfer protein (MTP) –493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients. J Viral Hepat 15(10):740–746.  https://doi.org/10.1111/j.1365-2893.2008.00994.x CrossRefGoogle Scholar
  8. 8.
    Talmud PJ, Palmen J, Miller G, Humphries SE (2000) Effect of microsomal triglyceride transfer protein gene variants (-493G>T, Q95H and H297Q) on plasma lipid levels in healthy middle-aged UK men. Ann Hum Genet 64(Pt 4):269–276.  https://doi.org/10.1017/S0003480000008150 CrossRefGoogle Scholar
  9. 9.
    Peng XE, Wu YL, Lu QQ, Hu ZJ, Lin X (2014) MTTP polymorphisms and susceptibility to non-alcoholic fatty liver disease in a Han Chinese population. Liver Int 34(1):118–128.  https://doi.org/10.1111/liv.12220 CrossRefGoogle Scholar
  10. 10.
    Magri MC, Prata TV, Manchiero C, Dantas BP, Mazza CC, Tengan FM (2017) Genetic variation in the microsomal triglyceride transfer protein (−493G/T) is associated with hepatic steatosis in patients infected with hepatitis C virus. BMC Infect Dis 17(1):235.  https://doi.org/10.1186/s12879-017-2340-x CrossRefGoogle Scholar
  11. 11.
    Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP et al (2008) Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology 134(2):416–423.  https://doi.org/10.1053/j.gastro.2007.11.010 CrossRefGoogle Scholar
  12. 12.
    The French METAVIR Cooperative Study Group (1994) Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 20(1):15–20.  https://doi.org/10.1002/hep.1840200104 CrossRefGoogle Scholar
  13. 13.
    Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41(6):1313–1321.  https://doi.org/10.1002/hep.20701 CrossRefGoogle Scholar
  14. 14.
    Karpe F, Lundahl B, Ehrenborg E, Eriksson P, Hamsten A (1998) A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels. Arterioscler Thromb Vasc Biol 18(5):756–761.  https://doi.org/10.1161/01.ATV.18.5.756 CrossRefGoogle Scholar
  15. 15.
    Ledmyr H, Karpe F, Lundahl B, McKinnon M, Skoglund-Andersson C, Ehrenborg E (2002) Variants of the microsomal triglyceride transfer protein gene are associated with plasma cholesterol levels and body mass index. J Lipid Res 43(1):51–58Google Scholar
  16. 16.
    Cai T, Dufour JF, Muellhaupt B, Gerlach T, Heim M, Moradpour D et al (2011) Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis. J Hepatol 55(3):529–535.  https://doi.org/10.1016/j.jhep.2010.12.020 CrossRefGoogle Scholar
  17. 17.
    Silva IS, Ferraz ML, Perez RM, Lanzoni VP, Figueiredo VM, Silva AE (2004) Role of gamma-glutamyl transferase activity in patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 19(3):314–318.  https://doi.org/10.1111/j.1440-1746.2003.03256.x CrossRefGoogle Scholar
  18. 18.
    Hwang SJ, Luo JC, Chu CW, Lai CR, Lu CL, Tsay SH et al (2001) Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation. J Gastroenterol Hepatol 16(2):190–195.  https://doi.org/10.1046/j.1440-1746.2001.02407.x CrossRefGoogle Scholar
  19. 19.
    Böhme M, Grallert H, Fischer A, Gieger C, Nitz I, Heid I et al (2008) MTTP variants and body mass index, waist circumference and serum cholesterol level: Association analyses in 7582 participants of the KORA study cohort. Mol Genet Metab 95(4):229–232.  https://doi.org/10.1016/j.ymgme.2008.09.004 CrossRefGoogle Scholar
  20. 20.
    Hsiao PJ, Lee MY, Wang YT, Jiang HJ, Lin PC, Yang YH et al (2015) MTTP-297H polymorphism reduced serum cholesterol but increased risk of non-alcoholic fatty liver disease-a cross-sectional study. BMC Med Genet 16:93.  https://doi.org/10.1186/s12881-015-0242-6 CrossRefGoogle Scholar
  21. 21.
    Kawaguchi T, Koga H, Torimura T (2017) Recent advances in the pathogenesis of hepatitis C virus-related non-alcoholic fatty liver disease and its impact on patients cured of hepatitis C. Curr Hepatology Rep 16:317–325.  https://doi.org/10.1007/s11901-017-0370-x CrossRefGoogle Scholar
  22. 22.
    Nirei K, Matsumura H, Kumakawa M, Matsumoto N, Nakamura H, Yamagami H et al (2017) Steatosis influences the clinical profiles and long-term outcomes of interferon-treated chronic hepatitis C and liver cirrhosis patients. Int J Med Sci 14(1):45–52.  https://doi.org/10.7150/ijms.17202 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2019

Authors and Affiliations

  • Thamiris Vaz Gago Prata
    • 1
  • Dayane de Souza Rodrigues da Silva
    • 1
  • Caroline Manchiero
    • 1
  • Bianca Peixoto Dantas
    • 1
  • Celso Carmo Mazza
    • 2
  • Arielle Karen da Silva Nunes
    • 1
  • Edson Abdala
    • 2
  • Gerusa Maria Figueiredo
    • 3
  • Fátima Mitiko Tengan
    • 1
    • 2
  • Mariana Cavalheiro Magri
    • 1
    Email author
  1. 1.Laboratorio de Investigacao Medica em Hepatologia por Virus (LIM-47), Hospital das Clinicas HCFMUSP, Faculdade de MedicinaUniversidade de Sao PauloSao PauloBrazil
  2. 2.Departamento de Molestias Infecciosas e Parasitarias, Hospital das Clinicas HCFMUSP, Faculdade de MedicinaUniversidade de Sao PauloSao PauloBrazil
  3. 3.Instituto de Medicina Tropical de Sao PauloUniversidade de Sao PauloSao PauloBrazil

Personalised recommendations